-

09:21:20 AM

AUGX Stock News

AUGX - Augmedix Inc

08/08/22 4:05 PM

Nasdaq : AUGX

earningslow float

Augmedix Reports Second Quarter 2022 Financial Results

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended June 30, 2022. “This quarter, we continued to see good momentum and are pleased with

RHEA-AI

neutral

08/08/22 4:01 PM

Nasdaq : AUGX

partnershiplow float

Augmedix Announces Expanded Partnership with Adventist Health

Augmedix , a leading provider of automated medical documentation solutions, announces an innovative, data-driven partnership with Adventist Health , a nonprofit integrated

RHEA-AI

very positive

08/03/22 8:00 AM

Nasdaq : AUGX

clinical triallow float

Augmedix - Trio Health - CIIC First of its Kind Real-World Patient Ecosystem - Standardizing Relevant Clinical Data at the Point of Care

Today, Trio Health (Trio) and Augmedix (Nasdaq: AUGX), in partnership with the Consortium of Independent Immunology Clinics (CIIC), announced the launch of an innovative platform to automate, standardize, and structure clinical patient data, right

RHEA-AI

very positive

07/25/22 4:05 PM

Nasdaq : AUGX

conferencesearningslow float

Augmedix to Report Second Quarter 2022 Financial Results on August 8, 2022

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the second quarter of 2022 on Monday, August 8, 2022, after market close. Company

RHEA-AI

neutral

05/26/22 4:05 PM

Nasdaq : AUGX

conferenceslow float

Augmedix to Present at the William Blair 42nd Annual Growth Stock Conference

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming William Blair Growth Stock Conference in Chicago. Augmedix’s management is

RHEA-AI

neutral

05/09/22 4:01 PM

Nasdaq : AUGX

earningslow float

Augmedix Reports First Quarter 2022 Financial Results

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended March 31, 2022. Manny Krakaris, Chief Executive Officer of Augmedix, commented, “We

RHEA-AI

neutral

04/25/22 4:05 PM

Nasdaq : AUGX

conferencesearningslow float

Augmedix to Report First Quarter 2022 Financial Results on May 9, 2022

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the first quarter of 2022 on Monday, May 9, 2022, after market close. Company management

RHEA-AI

neutral

03/29/22 4:05 PM

Nasdaq : AUGX

conferenceslow float

Augmedix to Participate at the 2022 Lytham Partners Spring Investor Conference

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming Lytham Partners Investors Conference, which will take place virtually from

RHEA-AI

neutral

03/29/22 8:00 AM

Nasdaq : AUGX

managementlow float

Augmedix Names William Febbo as New Member to its Board of Directors

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced that William Febbo, Chief Executive

RHEA-AI

very positive

03/21/22 4:05 PM

Nasdaq : AUGX

earningslow float

Augmedix Reports Fourth Quarter and Full Year 2021 Financial Results

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended December 31, 2021. “We are pleased with the progress we made in 2021, as we

RHEA-AI

neutral